NICE pauses appraisal cost recovery plan

The U.K.'s NICE said it will delay its plan to recover appraisal costs of drugs, medical devices and diagnostics until the U.K. government finishes its life sciences strategy.

NICE had planned to charge companies for appraisals so that the agency could be "more flexible and more responsive to changes in demand."...